|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01177 SINO BIOPHARM
Nominal 
8.060 -0.100 (-1.225%) | 2020/12 - Final RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | 2017/12 RMB(K¥) | 2016/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 5,324,634 | 5,094,364 | 3,732,518 | 2,994,865 |
| Net Cash from / (used in) Investing Activities | -- | (3,824,344) | (616,100) | (1,627,046) | (2,233,988) |
| Net Cash from / (used in) Financing Activities | -- | 2,800,837 | (2,177,744) | (1,698,065) | 567,379 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 4,301,127 | 2,300,520 | 407,407 | 1,328,256 |
| Cash & Cash Equivalents at beginning of period | -- | 6,235,029 | 3,692,044 | 3,502,435 | 2,121,085 |
| Effect of Foreign Exchange Rate Changes | -- | 95,054 | 242,465 | (217,798) | 53,094 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 10,631,210 | 6,235,029 | 3,692,044 | 3,502,435 |
| Remarks: | Real time quote last updated: 16/04/2021 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,771,086 |
| %Change | 0.346% |
| EPS / (LPS) | RMB 0.147 |
| NBV Per Share (¥) | RMB 0.888 |